These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20499158)

  • 1. RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway.
    Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Li QQ; Xu ZD; Liu XP
    Breast Cancer Res Treat; 2011 Apr; 126(3):555-63. PubMed ID: 20499158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
    Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
    Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
    Laezza C; Pisanti S; Malfitano AM; Bifulco M
    Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
    Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
    Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis.
    Yotova IY; Quan P; Leditznig N; Beer U; Wenzl R; Tschugguel W
    Hum Reprod; 2011 Apr; 26(4):885-97. PubMed ID: 21303778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
    Lepley D; Paik JH; Hla T; Ferrer F
    Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RACK1: A superior independent predictor for poor clinical outcome in breast cancer.
    Cao XX; Xu JD; Liu XL; Xu JW; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
    Int J Cancer; 2010 Sep; 127(5):1172-9. PubMed ID: 20020495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis.
    Kaartinen V; Haataja L; Nagy A; Heisterkamp N; Groffen J
    Int J Mol Med; 2002 Jun; 9(6):563-70. PubMed ID: 12011971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway.
    Oviedo PJ; Sobrino A; Laguna-Fernandez A; Novella S; Tarín JJ; García-Pérez MA; Sanchís J; Cano A; Hermenegildo C
    Mol Cell Endocrinol; 2011 Mar; 335(2):96-103. PubMed ID: 20615453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
    Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
    Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor 7 promotes tumor migration and invasiveness via the RhoA/ROCK pathway in metastatic squamous cell carcinoma of the head and neck.
    Xu Z; Zheng X; Yang L; Liu F; Zhang E; Duan W; Bai S; Safdar J; Li Z; Sun C
    Oncol Rep; 2015 Feb; 33(2):849-55. PubMed ID: 25434638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells.
    Gutjahr MC; Rossy J; Niggli V
    Exp Cell Res; 2005 Aug; 308(2):422-38. PubMed ID: 15950966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells.
    Yang Y; Wu N; Wang Z; Zhang F; Tian R; Ji W; Ren X; Niu R
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
    Bellovin DI; Simpson KJ; Danilov T; Maynard E; Rimm DL; Oettgen P; Mercurio AM
    Oncogene; 2006 Nov; 25(52):6959-67. PubMed ID: 16715134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
    Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R
    Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.